What is Mitraclip?
If your doctor has determined that you are too sick for open-heart surgery, you may be eligible for a less-invasive treatment option that is now available. This procedure is called transcatheter mitral valve repair (TMVR) with MitraClip therapy. This procedure does not require opening the chest or stopping the heart. Instead, through a vein in the leg, a thin tube (called a catheter) is guided to the mitral valve The MitraClip device is a small clip that is attached to your mitral valve. It treats mitral regurgitation by allowing your mitral valve to close more completely, helping to restore normal blood flow through your heart.
Is Mitraclip Experiment?
No. Mitraclip is NOT experimental. It is FDA approved for certain types of patients with mitral regurgitation. More then 25,000 patients have been treated with the MitraClip device globally.
What are the possible benefits of the MitraClip procedure?
Clinical trials demonstrate that patients who underwent the MitraClip procedure often demonstrate an immediate reduction of mitral regurgitation. These patients typically spent less than 2 days in the hospital. Many reported a significant improvement in symptoms and improvement in quality of life. These patients continued to experience improvement in their quality of life and ability to perform day-to-day tasks. They also required fewer visits to the hospital for problems related to their heart disease.
If your doctor has determined that you are too sick for open-heart surgery, you may be eligible for a less-invasive treatment option that is now available. This procedure is called transcatheter mitral valve repair (TMVR) with MitraClip therapy. This procedure does not require opening the chest or stopping the heart. Instead, through a vein in the leg, a thin tube (called a catheter) is guided to the mitral valve The MitraClip device is a small clip that is attached to your mitral valve. It treats mitral regurgitation by allowing your mitral valve to close more completely, helping to restore normal blood flow through your heart.
Is Mitraclip Experiment?
No. Mitraclip is NOT experimental. It is FDA approved for certain types of patients with mitral regurgitation. More then 25,000 patients have been treated with the MitraClip device globally.
What are the possible benefits of the MitraClip procedure?
Clinical trials demonstrate that patients who underwent the MitraClip procedure often demonstrate an immediate reduction of mitral regurgitation. These patients typically spent less than 2 days in the hospital. Many reported a significant improvement in symptoms and improvement in quality of life. These patients continued to experience improvement in their quality of life and ability to perform day-to-day tasks. They also required fewer visits to the hospital for problems related to their heart disease.